Neuralis - Suicide Risk Estimation with Artificial Intelligence

Important results from the project

From interviews within the health care system, it is clear that suicide risk assessment is one of the greatest difficulties in psychiatry. The feedback on our prototype was overall good. However, we believe that it is not possible to create a sustainable business model in Sweden because there are few incentives for improving the quality of the psychiatry and that the cost of suicides/suicide attempts does not fall primarily on the psychiatry part of the system. We have started to do an external validation in the form of a scientific article with the help of Sahlgrenska and Chalmers.

Expected long term effects

The idea of a better suicidal assessment tool is good and the problem exists. But we have not managed to find a business model that captures the value created. From the beginning, we had an optimistic view of the problem area, the way forward and the time to reach the goal, much due to the relatively small insights into the speed of the psychiatry. We had the goal of having a CE-marked product, but only doing what was needed to begin a CE marking would take a lot longer than the project time. Many other new insights and ideas have arisen during the course of the project, which can lead to new projects.

Approach and implementation

The majority of the work carried out has been done with internal resources to fully utilize the resources. Furthermore, we have arranged external help as we needed without costs, with the help of contacts and organizations. From October to December we had one who worked full time and from January we had two. Throughout the project, three to four have worked part-time with the project. We have participated in many conferences, workshops, and events offered in the area to create a large network. We had close contact with the staff and patients in the psychiatry.